Chase AIPricingFAQs
Display currency
Loading news…

Target PharmaSolutions

ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals.
Durham, North Carolina, United States Founded 2015 11-50 employees For Profit

TARGET PharmaSolutions based on the success of HCV-TARGET,

Total Funding
Available in Pro
Last Funding
Available in Pro
Acquisitions
0
Monthly Visits
Available in Pro
Contacts
6

Company Details

Funding & Financials

Pro
Total funding
Funding rounds
Last funding
Last funding type
Last funding date
Funding status
Total equity funding
Revenue range

IPO & Stock

IPO status
Private

Web Traffic

Pro
Monthly visits
Global traffic rank
6-mo avg visits
Visit duration (s)
Pages / visit
Bounce rate
Rank change (mo)

Technology & IP

Active technologies
20
Active products
11
IT spend
$9M

Company Info

Founded
2015
Employees
11-50
Operating status
Active
Company type
For Profit
Org types
company
Founders
4
News articles
3
HQ
Durham, North Carolina, United States
Region
Research Triangle, East Coast, Southern US
Diversity spotlight
Women Founded

Signals & Scores

Heat score
Low
Growth score
Low
Trend (7d)
0
Trend (30d)
-0.2
Trend (90d)
-0.1
Last leadership hire
Mar 16, 2020

Key People at Target PharmaSolutions

Co-Founder
Co-Founder
6
professional contacts at Target PharmaSolutions
Contact execs at Target PharmaSolutions

Explore 200,000+ acquisitions — free

Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.

Explore all acquisitions

Recent News related to Target PharmaSolutions

Loading news…

FAQs about Target PharmaSolutions

People who checked this page also checked these

Browse the full Acquirezy directory.
Target PharmaSolutions - Company Profile, Full Acquisitions List, Funding and Investments